SCHEMBL5232126

SCHEMBL5232126

O=[N+]([O-])c1cc(S(=O)(=O)Nc2cc(F)cc(F)c2)sc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPAS1 Q99814 6/20 0.40
ACLY P53396 2/20 0.40
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 2/20 0.35
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
IDH1 O75874 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
MMP13 P45452 1/20 0.34
VCAM1 P19320 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5231082 0.88 ALDH1A1 (0.43) MAPTTP53ALDH1A1GAAIDH1
SCHEMBL5233848 0.86 ACLY (0.39) EPAS1ACLYTP53ALDH1A1IDH1
SCHEMBL5230424 0.83 ALDH1A1 (0.49) EPAS1MAPTALDH1A1GAACA1
SCHEMBL5228196 0.82 CA12 (0.49) MAPTTP53ALDH1A1GAACA2
SCHEMBL5237280 0.82 CES1 (0.49) MAPTALDH1A1IDH1MEN1KMT2A
SCHEMBL5228023 0.81 CA2 (0.49) MAPTALDH1A1HDAC1CA1CA2
SCHEMBL5227180 0.81 LMNA (0.43) EPAS1CA1CA2MMP1MMP2
SCHEMBL5234203 0.80 ALDH1A1 (0.42) MAPTALDH1A1GAAIDH1CA1
SCHEMBL5227591 0.80 CDK1 (0.52) MAPTALDH1A1GAAIDH1MEN1
SCHEMBL5227928 0.80 MEN1 (0.50) EPAS1MAPTALDH1A1GAACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1519932-B1 BISARYLSULFONAMIDE COMPOUNDS AND THEIR USE IN CANCER THERAPY CYCLACEL LTD (GB) 2007-10-03 EP claimed